Market revenue in 2023 | USD 105.1 million |
Market revenue in 2030 | USD 235.1 million |
Growth rate | 12.2% (CAGR from 2023 to 2030) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & kits |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & kits, Services |
Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Roche, Fluidigm Corporation, Danaher Corp, Agilent Technologies, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Bio-Rad Laboratories Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genotyping market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 61.18% in 2023. Horizon Databook has segmented the South Africa genotyping market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in the prevalence of cancer in South Africa has led to increased need for advanced genotyping techniques for detection of cancer. Thus, increased need for rapid diagnosis has led to market growth. According to Lancet, South Africa is expected to witness 78% increase in cancer cases by 2030.
Moreover, investments to boost innovations that aim to address healthcare problems in the country are expected to increase. Many multinational companies, such as F. Hoffmann-La Roche AG, are forming joint ventures with local organizations, such as the Southern African Laboratory Diagnostics Association, which is a body representing and distributing IVD tests including genotyping tests in the region.
Owing to these factors, genotyping market in South Africa is anticipated to witness substantial growth during the forecast period. However, there are various challenges in harmonization of regulatory activities in the country. South Africa has the highest cancer prevalence in the region, which is contributing to the growth of genotyping, as it is used in biomedical research.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa genotyping market , including forecasts for subscribers. This country databook contains high-level insights into South Africa genotyping market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account